Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

RSS icon

BMJ: Lift age restriction on stroke thrombolysis

Thrombolysis within three hours of an acute stroke is effective in patients aged 40 to 90 years and should not be restricted in elderly patients, as current guidelines advise, according to a study published online Nov. 23 in the British Medical Journal.

$100K available to study policy impact on stroke care

The Emergency Medicine Foundation announced that Genentech has provided an educational grant to establish a research program to help determine how legislative and organizational protocols are impacting patient access to stroke treatment, as well as patient outcomes within the affected geographic areas.

Clarian Sees Success with Level I Vascular Emergency Program

Successful system-wide protocols to address the care of STEMI patients have spurred facilities like Clarian Cardiovascular at Methodist Hospital in Indianapolis to develop similar programs of facilitated care to treat other time-sensitive vascular emergencies such as aortic aneurysms and dissections. As a result, Clarian has reduced its time to treatment and mortality rates, while expanding its referral base.

New guidelines outline performance measures for PAD

To better define guidelines for the most optimal treatment approaches of peripheral artery disease (PAD), new American College of Cardiology Foundation/American Heart Association (ACCF/AHA) key performance measures aim too address how to best treat patients with PAD, because the guidelines are currrently unclearly defined.

VEITH: Endurant Endograft stent shows promise for AAAs

The implantable Endurant Endograft stent system (Medtronic) used in the minimally invasive treatment of abdominal aortic aneurysms (AAA) delivered strong results through one year of patient follow-up in the U.S. pivotal study, according to data at the 37th annual symposium of the Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium) in New York City.

AHA: Gene therapy for CLI fails to live up to initial hypenext stop, stem cells?

CHICAGO--NV1FGF 4 gene therapy did not prevent amputations or death among patients with critical limb ischemia (CLI) who were unsuitable for revascularization, based on the late-breaking TAMARIS phase III trial, presented today at the American Heart Association (AHA) Scientific Sessions.

El Camino's new vascular program combines endo, surgical

A new comprehensive vascular program, which combines endovascular and surgical experience, has gotten underway at the El Camino Hospital Los Gatos in California.

CSI to settle ev3 suit for $1M

Cardiovascular Systems will pay ev3, now part of Covidien, $1 million to settle 2007 litigation surrounding employees who joined CSI from ev3.

Displaying 1553 - 1560 of 1638

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.